ahlam1399
09-09-2015, 05:38 PM
UPDATE 1-FDA staff flags possible dosing risk with Collegium painkiller
Sept 9 (Reuters) - The U.S. Food and Drug Administration's staff expressed concerns over the risk of incorrectly administering Colleguim Pharmaceuticals Inc's long-acting opioid painkiller.
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2.img (http://da.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/ach.htm)http://pi.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49b2e178/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tR9Zlk8Vs0M:xgcPz4nl7EQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tR9Zlk8Vs0M:xgcPz4nl7EQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/tR9Zlk8Vs0M
Sept 9 (Reuters) - The U.S. Food and Drug Administration's staff expressed concerns over the risk of incorrectly administering Colleguim Pharmaceuticals Inc's long-acting opioid painkiller.
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2.img (http://da.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/ach.htm)http://pi.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385470442/u/49/f/654213/c/35217/s/49b2e178/sc/14/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49b2e178/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tR9Zlk8Vs0M:xgcPz4nl7EQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=tR9Zlk8Vs0M:xgcPz4nl7EQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=tR9Zlk8Vs0M:xgcPz4nl7EQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/tR9Zlk8Vs0M